1. Aims: What matters to the individual about their condition(s)?
Review diagnoses and consider:
- Therapeutic objectives of drug therapy
- Management of existing health problems
- Prevention of future health issues, including lifestyle advice
Ask person to complete PROMs (Questions to answer before medicines review) before their review
Person specific issues to address
- Concerned regarding side effects and possible ‘addiction’
- She feels original pain improved
- Gaining weight despite healthy diet
2. Need: Identify essential drug therapy
Identify essential drugs (not to be stopped without specialist advice)
- Drugs that have essential replacement functions (e.g. levothyroxine)
- Drugs to prevent rapid symptomatic decline (e.g. drugs for Parkinson’s disease, heart failure)
Person specific issues to address
3. Does the individual take unnecessary drug therapy?
Identify and review the continued need for drugs
- what is medication for?
- with temporary indications
- with higher than usual maintenance doses
- with limited benefit/evidence for use
- with limited benefit in the person under review (see Drug efficacy & applicability (NNT) table)
Person specific issues to address
- Pain improved. May not need higher dose gabapentin or full dose tramadol, both would need slowly reduced to avoid adverse effects of withdrawal. Reduce one at a time
4. Effectiveness: Are therapeutic objectives being achieved?
Identify the need for adding/intensifying drug therapy to achieve therapeutic objectives
- to achieve symptom control
- to achieve biochemical/clinical targets
- to prevent disease progression/exacerbation
- is there a more appropriate medication to achieve goals?
Person specific issues to address
- Pain improved overall
- Consider therapeutic paracetamol, if evidence of benefit. May need tramadol as required
5. Safety: Does the individual have or is at risk of ADR/ side effects? Does the patient know what to do if they’re ill?
Identify individual safety risks by checking for
Identify adverse drug effects by checking for
- specific symptoms/laboratory markers (e.g. hypokalaemia)
- cumulative adverse drug effects (see ADR table)
- drugs used to treat side effects caused by other drugs
Medication Sick Day guidance
- Ensure discussion and clear information on which medicines to withhold at times of dehydrating illness
Person specific issues to address
- Gabapentinoid and opioid both central nervous system depressant with risk of dependency
- Weight gain: gabapentin adverse effect includes abnormal appetite, therefore although diet is healthy may be consuming more. Previous pain and sedation could result in less physical activity. Increased weight can lead to joint pain
- Counsel and agreed shared decision to gradually reduce to lowest effective dose or stop
6. Sustainability: Is drug therapy cost-effective and environmentally sustainable?
Identify unnecessarily costly drug therapy by
- considering more cost-effective alternatives, formulary choices, safety, convenience
Consider the environmental impact of
- Inhaler use
- Single use plastics
- Medicines waste
- Water pollution
Person specific issues to address
- Consider non-pharmacological ways to manage pain
- Advised to dispose of medicines through the community pharmacy
- Advised to only order what is needed, do not stockpile medicines
7. Person-centredness: Is the person willing and able to take drug therapy as intended?
Does the person understand the outcomes of the review?
Ensure drug therapy changes are tailored to individual’s preferences. Consider
- is the medication in a form they can take?
- is the dosing schedule convenient?
- what assistance is needed?
- are they able to take medicines as intended?
Agree and communicate plan
- discuss and agree with the individual/carer/welfare proxy therapeutic objectives and treatment priorities
- include lifestyle and holistic management goals
- inform relevant health and social care providers of changes in treatments across the transitions of care
Ask person to complete PROMs (Questions to answer after medicines review) after their review
Agreed plan
- Discuss reduction plan advising that it may take several weeks or months to gradually reduce
- Discuss likely side effects of withdrawal and how to mitigate
- Explain the need to monitor pain, and stop at lowest effective dose if needed
- Could consider when required NSAID to help manage any flare up
- Additional steps: signpost to supported self-management and other allied team members to support activity management and pacing